Contact
searchSearch
HMP Global

July 2015 - FRMC

Ixekizumab for the Treatment of Plaque Psoriasis
07/30/2015
Eileen Koutnik-Fotopoulos
The UNCOVER-2 study found that ixekizumab (anti-interleuekin-17A IgG4 monoclonal antibody) was superior to placebo and etanercept in psoriasis patients.
The UNCOVER-2 study found that ixekizumab (anti-interleuekin-17A IgG4 monoclonal antibody) was superior to placebo and etanercept in psoriasis patients.
The UNCOVER-2 study found that...
07/30/2015
First Report Managed Care
Emerging Evidence and Future Direction of Chemoprevention in Pancreatic Cancer
07/30/2015
Mary Beth Nierengarten
Chemoprevention is used to target populations with preneoplastic lesions such as ductal in situ carcinoma and familial adenomatous polyposis.
Chemoprevention is used to target populations with preneoplastic lesions such as ductal in situ carcinoma and familial adenomatous polyposis.
Chemoprevention is used to...
07/30/2015
First Report Managed Care
Psoriasis Study Examines Cost per Responder with Biologics
07/30/2015
Eileen Koutnik-Fotopoulos
In a new study, researchers sought to evaluate the cost per additional responder associated with 4 biologics to achieve PASI 75, PASI 90, and PASI 100.
In a new study, researchers sought to evaluate the cost per additional responder associated with 4 biologics to achieve PASI 75, PASI 90, and PASI 100.
In a new study, researchers...
07/30/2015
First Report Managed Care
Pharmacist Intervention Among Patients With Comorbidities
07/30/2015
Eileen Koutnik-Fotopoulos
Philadelphia, PA—A brief pharmacist telephone intervention resulted in significantly better proportion of days covered (PDCs) during the 6 months following the intervention among a group of nonadherent patients with comorbid hypertension and...
Philadelphia, PA—A brief pharmacist telephone intervention resulted in significantly better proportion of days covered (PDCs) during the 6 months following the intervention among a group of nonadherent patients with comorbid hypertension and...
Philadelphia, PA—A brief...
07/30/2015
First Report Managed Care
Navigation Services Contribute to Improved Oncology Care at Reduced Cost
07/30/2015
With advances in cancer treatment, patients face increasingly more complex treatment and follow-up decisions that require efficient coordination within the health care system to optimize outcomes. 
With advances in cancer treatment, patients face increasingly more complex treatment and follow-up decisions that require efficient coordination within the health care system to optimize outcomes. 
With advances in cancer...
07/30/2015
First Report Managed Care
Look to Benefit Design Trends of Exchange Market for Formulary Management
07/30/2015
Mary Beth Nierengarten
“Although the exchange market is still small, it is important for the managed care industry to be on the forefront of trends in formulary management,” said Caroline Pearson, vice president, health reform and policy, Avalere Health,...
“Although the exchange market is still small, it is important for the managed care industry to be on the forefront of trends in formulary management,” said Caroline Pearson, vice president, health reform and policy, Avalere Health,...
“Although the exchange market is...
07/30/2015
First Report Managed Care

News

News
Study Examines Touch Avoidance in Psoriasis
07/30/2015
Eileen Koutnik-Fotopoulos
Vancouver, Canada—Severity of psoriasis has a significant impact on patient quality of life. In a new study, researchers conducted a cross-sectional survey among patients with psoriasis and included questions to assess the avoidance of...
Vancouver, Canada—Severity of psoriasis has a significant impact on patient quality of life. In a new study, researchers conducted a cross-sectional survey among patients with psoriasis and included questions to assess the avoidance of...
Vancouver, Canada—Severity of...
07/30/2015
First Report Managed Care

Department

Conference Insider
Antiplatelet Therapy for Acute Coronary Syndrome
07/30/2015
Eileen Koutnik-Fotopoulos
Orlando, FL—Antiplatelet and anticoagulant therapies are crucial in the management of patients with acute coronary syndrome (ACS). Platelet activation remains a major pathophysiological issue in ACS. Platelets upregulate the expression of...
Orlando, FL—Antiplatelet and anticoagulant therapies are crucial in the management of patients with acute coronary syndrome (ACS). Platelet activation remains a major pathophysiological issue in ACS. Platelets upregulate the expression of...
Orlando, FL—Antiplatelet...
07/30/2015
First Report Managed Care
Conference Insider
Adopting and Succeeding With Value-based Competition Model
07/30/2015
Mary Beth Nierengarten
Orlando, FL—Changes in the health care delivery system are placing demands on hospitals and physicians to become more competitive in a marketplace that is moving from fee-for-service payment models and pay-for-performance models to...
Orlando, FL—Changes in the health care delivery system are placing demands on hospitals and physicians to become more competitive in a marketplace that is moving from fee-for-service payment models and pay-for-performance models to...
Orlando, FL—Changes in the...
07/30/2015
First Report Managed Care
Conference Insider
Diagnosis and Management of IBD
07/30/2015
Inflammatory bowel disease (IBD) affects more than 1 million people in the United States. IBD encompasses a variety of clinical signs and symptoms including abdominal pain, diarrhea, and rectal bleeding.
Inflammatory bowel disease (IBD) affects more than 1 million people in the United States. IBD encompasses a variety of clinical signs and symptoms including abdominal pain, diarrhea, and rectal bleeding.
Inflammatory bowel disease (IBD)...
07/30/2015
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Improving Health Outcomes Through Early COPD and Asthma Intervention
10/04/2024
Hannah Musick
Research published in the New England Journal of Medicine shows that early diagnosis and treatment of undiagnosed COPD or asthma can reduce health care utilization for respiratory illness and improve overall health outcomes.
Research published in the New England Journal of Medicine shows that early diagnosis and treatment of undiagnosed COPD or asthma can reduce health care utilization for respiratory illness and improve overall health outcomes.
Research published in the New...
10/04/2024
First Report Managed Care
News
Advances in Factor IX Therapy Offer New Hope for Hemophilia B Treatment
10/23/2024
Lisa Kuhns, PhD, MD
New factor IX therapies promise improved treatment for hemophilia B.
New factor IX therapies promise improved treatment for hemophilia B.
New factor IX therapies promise...
10/23/2024
First Report Managed Care
News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
Jolynn Tumolo
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
Risk of Psychiatric Comorbidity Higher in Patients With Ankylosing Spondylitis
05/19/2023
Jolynn Tumolo
Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.
Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.
Findings from a...
05/19/2023
First Report Managed Care
Conference Coverage
Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens
06/08/2023
Maria Asimopoulos
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug...
06/08/2023
First Report Managed Care

July 2015 Volume 12 Issue 7

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use